A reality check of the accelerated approval of immune-checkpoint inhibitors

Nat Rev Clin Oncol. 2019 Nov;16(11):656-658. doi: 10.1038/s41571-019-0260-y. Epub 2019 Aug 5.
No abstract available

MeSH terms

  • Antineoplastic Agents, Immunological / therapeutic use*
  • Drug Approval*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Immunotherapy / methods*
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents, Immunological
  • Immunologic Factors